Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rienk Offringa

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatmentMariëtte I E van Poelgeest, Manon van Seters, Marc van Beurden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccineSjoerd H van der Burg, Anand G Menon, Anke Redeker, et al.
Molecular & Cellular Proteomics : MCP|August 7, 2024
optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input MaterialMogjiborahman Salek, Jonas D Förster, Jonas P Becker, et al.
Transplantation|January 2, 2004
Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cellsDave L Roelen, Danita H Schuurhuis, Daniëlle E M van den Boogaardt, et al.
Cancer Research|January 26, 2002
Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjectsAnnemieke de Jong, Sjoerd H van der Burg, Kitty M C Kwappenberg, et al.
Cancer Research|January 11, 2007
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancerSytse J Piersma, Ekaterina S Jordanova, Mariëtte I E van Poelgeest, et al.
Cancer Research|November 5, 2002
Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cellsSander Zwaveling, Michel P M Vierboom, Sandra C Ferreira Mota, et al.
Cancer Cell|January 22, 2011
An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cellsNicholas S Wilson, Becky Yang, Annie Yang, et al.
International Journal of Cancer|May 29, 2008
Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancerFrank M Speetjens, Marjolein M Lauwen, Kees L Franken, et al.
International Journal of Cancer|October 24, 2007
Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction elementSytse J Piersma, Marij J P Welters, Jeanette M van der Hulst, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatmentMariëtte I E van Poelgeest, Manon van Seters, Marc van Beurden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccineSjoerd H van der Burg, Anand G Menon, Anke Redeker, et al.
Molecular & Cellular Proteomics : MCP|August 7, 2024
optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input MaterialMogjiborahman Salek, Jonas D Förster, Jonas P Becker, et al.
Transplantation|January 2, 2004
Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cellsDave L Roelen, Danita H Schuurhuis, Daniëlle E M van den Boogaardt, et al.
Cancer Research|January 26, 2002
Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjectsAnnemieke de Jong, Sjoerd H van der Burg, Kitty M C Kwappenberg, et al.
Cancer Research|January 11, 2007
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancerSytse J Piersma, Ekaterina S Jordanova, Mariëtte I E van Poelgeest, et al.
Cancer Research|November 5, 2002
Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cellsSander Zwaveling, Michel P M Vierboom, Sandra C Ferreira Mota, et al.
Cancer Cell|January 22, 2011
An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cellsNicholas S Wilson, Becky Yang, Annie Yang, et al.
International Journal of Cancer|May 29, 2008
Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancerFrank M Speetjens, Marjolein M Lauwen, Kees L Franken, et al.
International Journal of Cancer|October 24, 2007
Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction elementSytse J Piersma, Marij J P Welters, Jeanette M van der Hulst, et al.
Pageof 12